Citáce podľa APA (7th ed.)

RY, M., Z, T., HY, H., C, Z., KX, M., DD, Z., . . . GB, W. (2025). Postoperative Adjuvant Transcatheterarterial Chemoembolization Should Be Considered Selectively for Patients with Cytokeratin-19 Positive Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma, 12(Issue 1), 2407-2419.

Citácia podle Chicago (17th ed.)

RY, Mai, et al. "Postoperative Adjuvant Transcatheterarterial Chemoembolization Should Be Considered Selectively for Patients with Cytokeratin-19 Positive Hepatocellular Carcinoma." Journal of Hepatocellular Carcinoma 12, no. Issue 1 (2025): 2407-2419.

Citácia podľa MLA (8th ed.)

RY, Mai, et al. "Postoperative Adjuvant Transcatheterarterial Chemoembolization Should Be Considered Selectively for Patients with Cytokeratin-19 Positive Hepatocellular Carcinoma." Journal of Hepatocellular Carcinoma, vol. 12, no. Issue 1, 2025, pp. 2407-2419.

Upozornenie: Tieto citáce sú generované automaticky. Nemusia byť úplne správne podľa citačných pravidiel..